Sigma Labs Reports First Quarter 2018 Financial Results


Sigma Labs, Inc.
Condensed Statements of Cash Flows
(Unaudited)

	Three Months Ended
	March 31, 2018			March 31, 2017
OPERATING ACTIVITIES
Net Loss	$	(1,170,876	)	$	(979,645	)
Adjustments to reconcile Net Loss to Net Cash used in operating activities:
Noncash Expenses:
Depreciation and Amortization		47,320			46,149
Stock Based Compensation		161,522			140,671
Loss on Write-off of Asset		36,733			-
Gain/Loss on Change in Derivative Balance		-			(93,206	)
Original Issue Discount Amortization		-			24,658
Debt Discount Amortization		-			56,441
Change in assets and liabilities:
Accounts Receivable		32,343			130,882
Interest Receivable		22,438			-
Inventory		76,324			(13,732	)
Prepaid Assets		(1,938	)		7,039
Accounts Payable		164,930			167,845
Deferred Revenue		24,351			35,680
Accrued Expenses		(5,396	)		36,665
NET CASH USED IN OPERATING ACTIVITIES		(612,249	)		(440,553	)

INVESTING ACTIVITIES
Purchase of Property and Equipment		(16,565	)		(33,000	)
Purchase of Intangible Assets		(39,542	)		(17,441	)
Advance of Funds for Note Receivable					(500,000	)
Proceeds from Note Receivable and Related Accrued Interest		500,000			-
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES		443,894			(550,441	)

FINANCING ACTIVITIES
Gross Proceeds from issuance of Common Stock and Warrants		-			5,823,300
Offering Costs Paid		-			(597,651	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		-			5,225,649

NET CHANGE IN CASH FOR PERIOD		(168,355	)		4,234,655

CASH AT BEGINNING OF PERIOD		1,515,674			398,391

CASH AT END OF PERIOD	$	1,347,319		$	4,633,046

Supplemental Disclosures:
Other noncash operating activities disclosure:
Issuance of Common Stock for services	$	40,000		$	51,408
Disclosure of cash paid for:
Interest	$	-		$	20,114
Income Taxes	$	-		$	-

« Previous Page 1 | 2 | 3 | 4 Next Page »